Prognostic genes of hepatocellular carcinoma based on gene coexpression network analysis
Authors:
- 18 February 2019
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (7) , 11616-11623
Abstract
Hepatocellular carcinoma (HCC) is the most common subtype in liver cancer whose prognosis is affected by malignant progression associated with complex gene interactions. However, there is currently no available biomarkers associated with HCC progression in clinical application. In our study, RNA sequencing expression data of 50 normal samples and 374 tumor samples was analyzed and 9225 differentially expressed genes were screened. Weighted gene coexpression network analysis was then conducted and the blue module we were interested was identified by calculating the correlations between 17 gene modules and clinical features. In the blue module, the calculation of topological overlap was applied to select the top 30 genes and these 30 genes were divided into the green group (11 genes) and the yellow group (19 genes) through searching whether these genes were validated by in vitro or in vivo experiments. The genes in the green group which had never been validated by any experiments were recognized as hub genes. These hub genes were subsequently validated by a new data set GSE76427 and KM Plotter Online Tool, and the results indicated that 10 genes (FBXO43, ARHGEF39, MXD3, VIPR1, DNASE1L3, PHLDA1, CSRNP1, ADR2B, C1RL, and CDC37L1) could act as prognosis and progression biomarkers of HCC. In summary, 10 genes who have never been mentioned in HCC were identified to be associated with malignant progression and prognosis of patients. These findings may contribute to the improvement of the therapeutic decision, risk stratification, and prognosis prediction for HCC patients.Keywords
This publication has 32 references indexed in Scilit:
- Transcriptional modules related to hepatocellular carcinoma survival: coexpression network analysisFrontiers of Medicine, 2016
- The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathwayGut, 2016
- A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinomaOncotarget, 2015
- Effects of short interfering RNA-mediated gene silencing of SKA1 on proliferation of hepatocellular carcinoma cellsScandinavian Journal of Gastroenterology, 2013
- Endothelial transdifferentiation in hepatocellular carcinoma: loss of Stabilin‐2 expression in peri‐tumourous liver correlates with increased survivalLiver International, 2013
- Frequent Amplification of CENPF, GMNN and CDK13 Genes in Hepatocellular CarcinomasPLOS ONE, 2012
- Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasionHepatology, 2012
- Genetic variants in novel pathways influence blood pressure and cardiovascular disease riskNature, 2011
- Transcriptomic analysis of autistic brain reveals convergent molecular pathologyNature, 2011
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008